KLYTE: POTASSIUM BICARBONATE EFFERVESCE.
POTASSIUM BICARBONATE EFFERVESCE. Key specifications include special_features: PRIMARY CONTAINER TYPE:INDIVIDUALLY WRAPPED;, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 30.000 TABLETS, active_medicament_medicinal_strength: 21.000 MILLIGRAMS CITRIC ACID ACTIVE INGREDIENT AND 2.500 MILLIGRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-153-6904, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | PRIMARY CONTAINER TYPE:INDIVIDUALLY WRAPPED; |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 30.000 TABLETS |
| active_medicament_medicinal_strength | 21.000 MILLIGRAMS CITRIC ACID ACTIVE INGREDIENT AND 2.500 MILLIGRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT |
| NSN | 6505-00-153-6904 |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES | PRIMARY CONTAINER TYPE:INDIVIDUALLY WRAPPED; |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 21.000 MILLIGRAMS CITRIC ACID ACTIVE INGREDIENT AND 2.500 MILLIGRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |
No substitute or cross-reference records for this part.